Dermata announces Aug 25 launch of Tome Foundational Treatment at $178 per set

Dermata Therapeutics, Inc.

First commercial product Tome Foundational Treatment launches August 25, 2026; waitlist gets early preorder access.
Four once-weekly treatments per set, priced at $178 (approx $45/treatment), sold exclusively at tomeskincare.com.
Company shifts to commercialize skincare products, reducing regulatory burdens and expanding consumer market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.